Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Primary Target Pathway Mean Normalized Growth Rate Inhibition Value Increased Fraction Dead
HCC1428 Taselisib
0.001
PI3Ka, g, d
PI3K/mTOR
 1.0305 0.00006
HCC1428 Taselisib
0.0031623
PI3Ka, g, d
PI3K/mTOR
 0.9700 0.00244
HCC1428 Taselisib
0.01
PI3Ka, g, d
PI3K/mTOR
 1.0865 0.00596
HCC1428 Taselisib
0.031623
PI3Ka, g, d
PI3K/mTOR
 0.9905 0.00082
HCC1428 Taselisib
0.1
PI3Ka, g, d
PI3K/mTOR
 0.8814 0.01245
HCC1428 Taselisib
0.31623
PI3Ka, g, d
PI3K/mTOR
 0.8845 0.00355
HCC1428 Taselisib
1.0
PI3Ka, g, d
PI3K/mTOR
 0.9055 0.01012
HCC1428 Taselisib
3.1623
PI3Ka, g, d
PI3K/mTOR
 0.5655 0.02918
HCC1428 Taselisib
10.0
PI3Ka, g, d
PI3K/mTOR
 0.1734 0.10781
HCC1428 TGX221
0.001
PI3Kb
PI3K/mTOR
 1.1327 0.00456
HCC1428 TGX221
0.0031623
PI3Kb
PI3K/mTOR
 0.9202 0.00052
HCC1428 TGX221
0.01
PI3Kb
PI3K/mTOR
 1.0763 0.00096
HCC1428 TGX221
0.031623
PI3Kb
PI3K/mTOR
 1.0395 0.00689
HCC1428 TGX221
0.1
PI3Kb
PI3K/mTOR
 1.0296 0.00101
HCC1428 TGX221
0.31623
PI3Kb
PI3K/mTOR
 0.9631 -0.00155
HCC1428 TGX221
1.0
PI3Kb
PI3K/mTOR
 1.0406 0.00158
HCC1428 TGX221
3.1623
PI3Kb
PI3K/mTOR
 0.9333 0.00032
HCC1428 TGX221
10.0
PI3Kb
PI3K/mTOR
 0.7695 0.01533
HCC1428 Torin2
0.0001
mTOR/ATM/ATR
PI3K/mTOR
 0.9850 0.00698
HCC1428 Torin2
0.00031623
mTOR/ATM/ATR
PI3K/mTOR
 1.0780 -0.00215
HCC1428 Torin2
0.001
mTOR/ATM/ATR
PI3K/mTOR
 1.0841 0.00186
HCC1428 Torin2
0.0031623
mTOR/ATM/ATR
PI3K/mTOR
 0.8025 0.00662
HCC1428 Torin2
0.01
mTOR/ATM/ATR
PI3K/mTOR
 0.5681 0.02550
HCC1428 Torin2
0.031623
mTOR/ATM/ATR
PI3K/mTOR
 0.2565 0.05576
HCC1428 Torin2
0.1
mTOR/ATM/ATR
PI3K/mTOR
 0.1365 0.08363